CompletedNot Applicable

Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)

Zambia225 participantsStarted 2016-10-16

Plain-language summary

The purpose of the study is to find out if individuals who received first and second dose of Oral Cholera Vaccine (OCV) in Lukanga Swamps, Central Province of Zambia have developed protection against future attacks to cholera. The investigators also want to investigate whether vitamin A deficiency and being HIV positive increases the chances of suffering from cholera.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants aged 18-65 years are eligible to participate. * Participant is a resident of the study area. Residence was defined as individuals living in the study area for the past 1 year. * Written consent provided by participant. Exclusion Criteria: * Participant aged less than 18 years * Refuses to consent to participate * Pregnancy * Participant has acute medical illness prior to receipt of oral cholera vaccine -Participant has a history of hospitalization for cholera in the past one week

What they're measuring

Vibriocidal

Timeframe: 4 years

Trial details

NCT IDNCT04423159

SponsorCentre for Infectious Disease Research in Zambia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-10-31

View on ClinicalTrials.gov More Diarrhea Infectious trials